These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 16679848)

  • 1. An update on chemoprevention strategies in prostate cancer for 2006.
    Neill MG; Fleshner NE
    Curr Opin Urol; 2006 May; 16(3):132-7. PubMed ID: 16679848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on prostate cancer chemoprevention.
    Lowe JF; Frazee LA
    Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on chemoprevention for prostate cancer.
    Strope SA; Andriole GL
    Curr Opin Urol; 2010 May; 20(3):194-7. PubMed ID: 20216317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer chemoprevention: current status and future prospects.
    Gupta S
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of prostate cancer: agents and study designs.
    Thompson IM
    J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological approaches to reducing the risk of prostate cancer.
    Rittmaster RS; Fleshner NE; Thompson IM
    Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of prostate cancer.
    Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Klein EA
    J Urol; 2009 Aug; 182(2):499-507; discussion 508. PubMed ID: 19524966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
    Pak RW; Lanteri VJ; Scheuch JR; Sawczuk IS
    Integr Cancer Ther; 2002 Dec; 1(4):338-44. PubMed ID: 14664728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
    Fujimoto N; Chang C; Nomura M; Matsumoto T
    Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future status of prostate cancer chemoprevention.
    Fujimoto N; Nomura M; Matsumoto T
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):59-71. PubMed ID: 16375645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer: chemoprevention update 2005.
    Fleshner N; Al Azab R
    Can J Urol; 2005 Jun; 12 Suppl 2():2-4. PubMed ID: 16018824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice.
    Canby-Hagino ED; Thompson IM
    Nat Clin Pract Oncol; 2005 May; 2(5):255-61. PubMed ID: 16264961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of prostate cancer.
    Klein EA
    Crit Rev Oncol Hematol; 2005 Apr; 54(1):1-10. PubMed ID: 15780904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III prostate cancer prevention trials: are the costs justified?
    Thompson IM; Tangen CM; Klein EA; Lippman SM
    J Clin Oncol; 2005 Nov; 23(32):8161-4. PubMed ID: 16278467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part II.
    Moyad MA
    Urol Oncol; 2004; 22(6):472-7. PubMed ID: 15610864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part I.
    Moyad MA
    Urol Oncol; 2004; 22(6):466-71. PubMed ID: 15610863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in the risk of prostate cancer: future directions after the Prostate Cancer Prevention Trial.
    Crawford ED; Andriole GL; Marberger M; Rittmaster RS
    Urology; 2010 Mar; 75(3):502-9. PubMed ID: 20035983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of finasteride on risk of prostate cancer: how little we really know.
    Rubin MA; Kantoff PW
    J Cell Biochem; 2004 Feb; 91(3):478-82. PubMed ID: 14755678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of prostate cancer chemoprevention: a decision analysis model.
    Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1485-9. PubMed ID: 16896037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of prostate cancer. Part 1: chemoprevention.
    Sooriakumaran P
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):419-25. PubMed ID: 16503858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.